Clinical trials
Recruiting Congenital Abnormalities trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Johns Hopkins University | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Anova Enterprises, Inc | 1 |
| Baylor College of Medicine | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Heartland Health Research Alliance | 1 |
| Indiana University | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Congenital Abnormalities | 22 |
| Heart Defects, Congenital | 3 |
| Abnormalities, Multiple | 2 |
| Blast Crisis | 2 |
| Burkitt Lymphoma | 2 |
| Cardiovascular Abnormalities | 2 |
| Cardiovascular Diseases | 2 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 2 |
| Disorders of Sex Development | 2 |
| Hodgkin Disease | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.